Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 127331
Published online Jan 21, 2027. doi: 10.3748/wjg.127331
Published online Jan 21, 2027. doi: 10.3748/wjg.127331
Figure 1 The flow chart for patients enrolled.
VA: Vonoprazan-amoxicillin dual therapy; VBAM: Vonoprazan-bismuth-amoxicillin-minocycline quadruple therapy; ITT: Intention-to-treat; mITT: Modified intention-to-treat; PP: Per-protocol; UBT: Urea breath test.
- Citation: Chen JH, Liu XW, Xu YT, Wang N, Guo JF, Chen LY, Gao FS, Zhang C. Randomized trial of vonoprazan dual therapy vs bismuth-containing quadruple therapy with two low-resistance antibiotics for Helicobacter pylori eradication. World J Gastroenterol 2027; 33(3): 127331
- URL: https://www.wjgnet.com/1007-9327/full/v33/i3/127331.htm
- DOI: https://dx.doi.org/10.3748/wjg.127331